期刊文献+

脱钙骨基质的临床应用与研究进展 被引量:5

Clinical Application and Research Progress of Demineralized Bone Matrix
下载PDF
导出
摘要 脱钙骨基质是一种具有骨传导和骨诱导性质的生物材料,以多种形式应用于临床治疗四肢长骨骨缺损,并取得了令人满意的效果。脱钙骨基质是由胶原蛋白、非胶原蛋白以及较低浓度的生长因子(如骨形态发生蛋白)等组成的复合物,具有良好的生物学特性、骨诱导及骨传导活性,可生物降解,促进新骨形成及骨组织矿化,加速骨愈合,是骨组织工程比较理想的支架材料,可以单独或者与自体骨及其他生物材料或者生长因子联合运用有效修复骨缺损。 Demineralized bone matrix(DBM) is an osteoconductive and osteoinductive biomaterial and approved medical device used in bone defects with a long track record of clinical use in diverse forms.DBM retains collagen proteins,non-collagen proteins and growth factors of low concentration,such as BMP.DBM provides a degradable matrix facilitating endogenous release of these compounds to the bone wound sites where it is surgically placed to ll bone defects,inducing new bone formation and accelerating healing.DBM is the ideal scaffold material for bone tissue engineering,alone or in combination with autologous bone or growth factors for bone defects repairing.
作者 张鸣 李翔
出处 《医学综述》 2013年第14期2540-2543,共4页 Medical Recapitulate
关键词 脱钙骨基质 骨移植 骨形态发生蛋白 组织再生 骨诱导 Demineralized bone matrix Bone graft Bone morphogenetic protein Tissue regeneration Osteoconduction
  • 相关文献

参考文献27

  • 1Urist MR.Bone:formation by autoinduction[J].Science,1965,150(3698):893-899.
  • 2Urist MR.Solubilized and insolubilized bone morphogenetic protein[J].Proc Natl Acad Sci USA,1979,76(4):1828-1932.
  • 3Hunter SA,Orheim R,Sazon M,et al..Demineralization removesresidual alendronate in allograft bone procured from donors with ahistory of bisphosphonate use[J].J Periodontol,2011,82(2):281-286.
  • 4Schwartz Z,Hyzy SL,Moore MA,et al..Osteoinductivity of demi-neralized bone matrix is independent of donor bisphosphonate use[J].J Bone Joint Surg Am,2011,93(24):2278-2286.
  • 5Wang JC,Alanay A,Mark D,et al.A comparison of commerciallyavailable demineralized bone matrix for spinal fusion[J].EurSpine J,2007,16(8):1233-1240.
  • 6Jin L,Wan Y,Shimer AL,et al..Intervertebral disk-like biphasicscaffold-demineralized bone matrix cylinder and poly(polycaprolac-tone triol malate)-for interbody spine fusion[J].J Tissue Eng,2012,3(1):2041731412454420.
  • 7Bostrom MP,Yang X,Kennan M,et al.An unexpectedoutcome dur-ing testing of commercially available demineralized bone graft mate-rials:how safe are the nonallograft components?[J].Spine(PhilaPa 1976),2001,26(13):1425-1428.
  • 8Glowacki J.A review of osteoinductive testing methods and sterili-zation processes for demineralized bone[J].Cell Tissue Bank,2005,6(1):3-12.
  • 9Munting E,Wilmart JF,Wijne A,et al.Effect of sterilization onosteoinduction.Comparison of five methods in demineralized ratbone[J].Acta Orthop Scand,1988,59(1):34-38.
  • 10Glowacki J,Mulliken JB.Demineralized bone implants[J].ClinPlast Surg,1985,12(2):233-241.

二级参考文献28

共引文献6

同被引文献67

  • 1陈书军 ,裴国献 ,郭刚 ,陈滨 ,金丹 ,杨志明 .纤维蛋白在软骨组织工程中的应用[J].国外医学(生物医学工程分册),2005,28(4):249-253. 被引量:4
  • 2郭晓忠,窦宝信,周乙雄,李玉军.股骨头髓心减压加异体腓骨移植术治疗股骨头坏死[J].中国修复重建外科杂志,2005,19(9):697-699. 被引量:27
  • 3Alsaleh KA,Tougas CA,Roffey DM,et al.Osteoconductive bone graft extenders in posterolateral thoracolumbar spinal fusion: a systematic review.Spine (Phila Pa 1976). 2012; 37(16): E993-1000.
  • 4Bessa PC,Casal M,Reis RL.Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery).J Tissue Eng Regen Med. 2008; 2(2-3): 81-96.
  • 5Lee SS, Huang BJ, Kaltz SR, et al.Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within couaqen scaffolds. Biomaterials.2013; 34(2): 452-459.
  • 6Venkatesan J, Bhatnagar I, Manivasagan P, et al. Alginate composites for bone tissue engineering: a review. Int J Bioi Macromol.2015;72:269-281.
  • 7Abbah SA, Liu J, Goh JC,et aLEnhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic protei n-2. Tissue Eng Part A. 2013; 19(3-4 ): 350-359.
  • 8Koo KH,Yeo do H, Ahn JM,et aLLumbar posterolateral fusion using heparin-conjugated fibrin for sustained delivery of bone morphogenic protein-2 in a rabbit model.Artif Organs. 2012; 36(7): 629-634.
  • 9Ben-David 0, Srouji S, Shapira-Schweitzer Ket al.Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hyd rogel matrix. Biomaterials. 2013; 34( 12): 2902-2910.
  • 10Biswas 0, Bible JE, Whang PH,et aLAugmented demineralized bone matrix: x a potential alternative for posterolateral lumbar spinal fusion.Am J Orthop (Belle Mead NJ). 2010;39(11 ):531-538.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部